Research

GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.

Evotec will receive undisclosed upfront, milestone and tiered royalty payments totalling up to $1bn.

Abbisko is eligible to receive up to $258m in milestone payments from Lilly.

GSK noted that the bids ‘fundamentally undervalued’ the Consumer Healthcare business.

Cancer, infections and heart disease pose the greatest risk to kidney transplant recipients ― not organ rejection ― according to a recently published Mayo Clinic study.

Enhanced access to regenerative treatments is needed so new healing solutions become broadly available in clinical care, according to Mayo Clinic research.

The companies collaborated initially in 2019 to use AI and machine learning to develop new therapies for CKD and IPF.

Following Medicare's Decision to Cover New Drug Only for Patients in Clinical Trials, Cedars-Sinai Experts Explain the Latest Advances in Alzheimer’s Diagnostic Techniques and Treatments